Clinical trials
Phase 1/2 Neurodegenerative Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amylyx Pharmaceuticals Inc. | 1 |
| ClusterXStem-Costa Rica | 1 |
| Maimónides Biomedical Research Institute of Córdoba | 1 |
| Renishaw | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 5 |
| Parkinson Disease | 3 |
| Nervous System Diseases | 2 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Motor Neuron Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.